Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP668347.RAJy3LXBA9C70n0dq0KBE4iU-mHPBt5Ny98LRliDOPt1o130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP668347.RAJy3LXBA9C70n0dq0KBE4iU-mHPBt5Ny98LRliDOPt1o130_assertion type Assertion NP668347.RAJy3LXBA9C70n0dq0KBE4iU-mHPBt5Ny98LRliDOPt1o130_head.
- NP668347.RAJy3LXBA9C70n0dq0KBE4iU-mHPBt5Ny98LRliDOPt1o130_assertion description "[To the best of our knowledge, this is the first prospective analysis in which the prognostic impact of a relatively high number of antigenic markers has been simultaneously analyzed in a large series of uniformly treated patients, showing that the expression of several antigens (particularly CD28 and CD117) on bone marrow plasma cells from patients with MM can help to identify patients at high risk of progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP668347.RAJy3LXBA9C70n0dq0KBE4iU-mHPBt5Ny98LRliDOPt1o130_provenance.
- NP668347.RAJy3LXBA9C70n0dq0KBE4iU-mHPBt5Ny98LRliDOPt1o130_assertion evidence source_evidence_literature NP668347.RAJy3LXBA9C70n0dq0KBE4iU-mHPBt5Ny98LRliDOPt1o130_provenance.
- NP668347.RAJy3LXBA9C70n0dq0KBE4iU-mHPBt5Ny98LRliDOPt1o130_assertion SIO_000772 18443352 NP668347.RAJy3LXBA9C70n0dq0KBE4iU-mHPBt5Ny98LRliDOPt1o130_provenance.
- NP668347.RAJy3LXBA9C70n0dq0KBE4iU-mHPBt5Ny98LRliDOPt1o130_assertion wasDerivedFrom befree-2016 NP668347.RAJy3LXBA9C70n0dq0KBE4iU-mHPBt5Ny98LRliDOPt1o130_provenance.
- NP668347.RAJy3LXBA9C70n0dq0KBE4iU-mHPBt5Ny98LRliDOPt1o130_assertion wasGeneratedBy ECO_0000203 NP668347.RAJy3LXBA9C70n0dq0KBE4iU-mHPBt5Ny98LRliDOPt1o130_provenance.